The main finding of this study is that high-dose allopurinol
reduces LVM in patients with IHD and LVH who are on
current evidence-based optimal therapy. The secondary
findings are that high-dose allopurinol reduces LV endsystolic
volume and improves endothelial function and
arterial stiffness.